RT Journal Article
SR Electronic
T1 Public-private partnership to rapidly strengthen and scale COVID-19 response in Western Kenya
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2021.08.31.21262891
DO 10.1101/2021.08.31.21262891
A1 van Duijn, Shannen
A1 Barsosio, Hellen C.
A1 Omollo, Mevis
A1 Milimo, Emmanuel
A1 Akoth, Isdorah
A1 Aroka, Robert
A1 de Sanctis, Teresa
A1 K’Oloo, Alloys
A1 June, Micah J.
A1 Houben, Nathalie
A1 Wilming, Charlotte
A1 Otieno, Kephas
A1 Kariuki, Simon
A1 Onsongo, Simon
A1 Odhiambo, Albert
A1 Ganda, Gregory
A1 de Wit, Tobias F. Rinke
YR 2022
UL http://medrxiv.org/content/early/2022/07/13/2021.08.31.21262891.abstract
AB INTRODUCTION In Africa almost half of healthcare services are delivered through private sector providers. These are often underused in national public health responses. In line with our previous HIV experience and to support and accelerate the public sector’s COVID-19 response, we initiated a public-private project (PPP) in Kisumu County, Kenya. In this manuscript we demonstrate this PPP’s performance, using COVID-19 testing as an aggregator and with semi-real time digital monitoring tools for rapid scaling of COVID-19 response.METHODS COVID-19 diagnostic testing formed the basis for a PPP between KEMRI, Department of Health Kisumu County, PharmAccess Foundation, and local faith-based and private healthcare facilities: COVID-Dx. COVID-Dx was implemented from June 01, 2020, to March 31, 2021 in Kisumu County, Kenya. Trained laboratory technologists in participating healthcare facilities collected nasopharyngeal and oropharyngeal samples from patients meeting the Kenyan MoH COVID-19 case definition. Samples were rapidly transported by motorbike and tested using RT-PCR at the central reference laboratory in KEMRI. Healthcare workers in participating facilities collected patient clinical data using a digitized MoH COVID-19 Case Identification Form. We shared aggregated results from these data via (semi-) live dashboards with all relevant stakeholders through their mobile phones. Statistical analyses were performed using Stata 16 to inform project processes.RESULTS Nine private facilities participated in the project. A detailed patient trajectory was developed from case identification to result reporting, all steps supported by a semi-real time digital dashboard. A total of 4,324 PCR tests for SARS-CoV-2 (16%) were added to the public response, identifying 425 positives. Geo-mapped and time-tagged information on incident cases was depicted on Google maps dashboards and fed back to policymakers for informed rapid decision making. Preferential COVID-19 testing was performed on health workers at risk, with 1,009 tested (43% of all County health workforce).CONCLUSION We demonstrate feasibility of rapidly increasing the public health sector response to a COVID-19 epidemic outbreak in an African setting. Our PPP intervention in Kisumu, Kenya was based on a joint testing strategy and demonstrated that semi-real time digitalization of patient trajectories in the healthcare system can gain significant efficiencies, linking public and private healthcare efforts, increasing transparency, support better quality health services and informing policy makers to target interventions. This PPP has since scaled to 33 facilities in Kisumu and subsequently to 84 sites in 14 western Kenyan Counties.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis project was financially supported by Achmea Foundation, Pfizer Foundation, and the Netherlands Ministry of Foreign Affairs. Grant/Award numbers for all funders: N/A. The funders did not have any role in study design, data collection, analysis, interpretation, summarizing the data or decision to submit the manuscript for publication.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Ethical clearance for this project was obtained from Jaramogi Oginga Odinga Teaching & Referral Hospital (JOOTRH) on June 16, 2020, with approval number IERC/JOOTRH/230/2020. KEMRI also provided ethical clearance on September 30, 2020, with approval number KEMRI KEMRI/SERU/CGHR/05-05/4038. Research License was obtained from the National Commission for Science, Technology, and Innovation (NACOSTI) on July 6, 2020 (NACOSTI/P/20/5616). The roll-out of this project was in complete coordination with the Kisumu Department of Health. Sample collection in patients in this project was voluntary.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesDue to the privacy of patient data, datasets associated with this project are not publicly available. Anonymized and aggregated data are available from the authors upon request.CCIFCOVID Case Identification FormCOVAXCOVID-19 Global Vaccine AccessCOVID-19coronavirus disease of 2019DoHDepartment of HealthGDPRGeneral Data Protection RegulationGFATMThe Global Fund to FightAIDSTuberculosis and MalariaHIPAAHealth Insurance Portability and Accountability Act of 1996KEMRIKenya Medical Research Institute –LMIClow- and middle-income countriesMoHMinistry of HealthNGOnon-governmental organizationPCRpolymerase chain reactionPEPFARPresident’s Emergency Plan for AIDS ReliefPPEpersonal protective equipmentPPPpublic-private partnershipRDTrapid diagnostic test –RNARibonucleic acidToTtrainers of trainersUHCuniversal health coverageVTMviral transport medium –WHOWorld Health Organization